

Cover Story
Conversation with The Cancer Letter
After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.
In Brief


Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for April 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out
- Shane Jacobson named CEO of the American Cancer Society, ACS CAN
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?